“By dividing and conquering…we’re seeing responses in multiple different subtypes of sarcoma…and moving toward more of an individualized therapy that we try to design for every patient, where we take ...

A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.

Recent trials reveal promising advancements in targeted therapies for chondrosarcomas and tenosynovial giant cell tumors.

Scientists at NYU Abu Dhabi have developed an innovative use for nanotechnology in the field of cancer research. Their ...

New study reveals a central role of selenoprotein GPX3 in attenuating acute kidney injury Renal ischemia–reperfusion injury ...

Study Highlights the Efficacy of PMC in Suppressing Non-Small Cell Lung Cancer Growth SEOUL, SOUTH KOREA, January 23, 2026 ...

Northwestern Medicine scientists in the laboratory of Stephen Miller, Ph.D., professor emeritus of Microbiology–Immunology, have identified the cellular and molecular mechanisms required for the ...

Chordoma is a rare tumor characterized by poor prognosis, limited therapeutic options, and a high rate of recurrence. Despite ...

Cells operate on rules not vibes, including when on the precipice of persisting or perishing. Yet, with prior research ...

Chordoma is a rare, treatment-resistant tumor with limited therapeutic options and a high rate of recurrence. In a recent ...

A new study published in Pharmaceuticals and conducted by researchers from McGill University sheds light on how cannabidiol ...

In-line dielectric spectroscopy enables early apoptosis detection, improving CHO cell health, control strategies, and productivity.